Perrigo Puchases Fera Pharma $93 Milion In Cash, Contingent Payments
ALLEGAN - Perrigo Co. said Monday it had purchased the ophthalmic sterile ointment and solution portfolio of Fera Pharmaceuticals LLC and its affiliates for an upfront payment of $93 million along with potential contingent payments of $36 million, some of which relate to Perrigo securing more product rights from Fera. Perrigo said the purchase expands